PT Metro Healthcare Indonesia Tbk (ISX:CARE) Piotroski F-Score: 8 (As of Jun. 28, 2026) — 100% Above Median


ISX:CARE PT Metro Healthcare Indonesia Tbk ISX:CARE
77 GF Score
Price Rp414.00
GF Value Rp364.97
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PT Metro Healthcare Indonesia Tbk Piotroski F-Score?

PT Metro Healthcare Indonesia Tbk ISX:CARE -0.96% 77 Piotroski F-Score is 8 as of Jun. 28, 2026, which is 100% above its 10-year median of 4.00. GuruFocus rates ISX:CARE with a GF Score™ of 77/100 and a GF Value™ of Rp364.97 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 650 Healthcare Providers & Services companies, PT Metro Healthcare Indonesia Tbk ranks better than 97.38% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Metro Healthcare Indonesia Tbk has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for PT Metro Healthcare Indonesia Tbk's Piotroski F-Score or its related term are showing as below:

ISX:CARE' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 8
Current: 8

During the past 10 years, the highest Piotroski F-Score of PT Metro Healthcare Indonesia Tbk was 8. The lowest was 3. And the median was 4.

PT Metro Healthcare Indonesia Tbk  (ISX:CARE) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PT Metro Healthcare Indonesia Tbk Piotroski F-Score Related Terms


PT Metro Healthcare Indonesia Tbk Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for PT Metro Healthcare Indonesia Tbk's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Metro Healthcare Indonesia Tbk Piotroski F-Score Chart

PT Metro Healthcare Indonesia Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 3.00 3.00 4.00 8.00

PT Metro Healthcare Indonesia Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 6.00 8.00 8.00

ISX:CARE vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Metro Healthcare Indonesia Tbk Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's Piotroski F-Score falls into.


ISX:CARE
77GF Score
PT Metro Healthcare Indonesia Tbk ISX:CARE
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 30286.723 + 1049.769 + 2639.601 + 140.691 = Rp34,117 Mil.
Cash Flow from Operations was 38236.291 + 16503.435 + 14350.729 + 15186.154 = Rp84,277 Mil.
Revenue was 80994.863 + 77223.201 + 204488.588 + 120221.255 = Rp482,928 Mil.
Gross Profit was 62316.606 + 33859.756 + 93103.004 + 64850.803 = Rp254,130 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(3981492.936 + 3895283.189 + 4186931.689 + 4175928.931 + 4173566.928) / 5 = Rp4082640.7346 Mil.
Total Assets at the begining of this year (Mar25) was Rp3,981,493 Mil.
Long-Term Debt & Capital Lease Obligation was Rp525,985 Mil.
Total Current Assets was Rp515,845 Mil.
Total Current Liabilities was Rp615,639 Mil.
Net Income was -23270.663 + -24027.419 + -10910.097 + -29023.375 = Rp-87,232 Mil.

Revenue was 84568.475 + 72932.406 + 80639.18 + 77044.954 = Rp315,185 Mil.
Gross Profit was 23943.366 + 21714.962 + 30545.676 + 25878.222 = Rp102,082 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(4086346.595 + 4055631.183 + 4014238.193 + 4021105.412 + 3981492.936) / 5 = Rp4031762.8638 Mil.
Total Assets at the begining of last year (Mar24) was Rp4,086,347 Mil.
Long-Term Debt & Capital Lease Obligation was Rp111,115 Mil.
Total Current Assets was Rp505,463 Mil.
Total Current Liabilities was Rp874,075 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Metro Healthcare Indonesia Tbk's current Net Income (TTM) was 34,117. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Metro Healthcare Indonesia Tbk's current Cash Flow from Operations (TTM) was 84,277. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=34116.784/3981492.936
=0.00856884

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-87231.554/4086346.595
=-0.02134708

PT Metro Healthcare Indonesia Tbk's return on assets of this year was 0.00856884. PT Metro Healthcare Indonesia Tbk's return on assets of last year was -0.02134708. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PT Metro Healthcare Indonesia Tbk's current Net Income (TTM) was 34,117. PT Metro Healthcare Indonesia Tbk's current Cash Flow from Operations (TTM) was 84,277. ==> 84,277 > 34,117 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=525984.835/4082640.7346
=0.12883447

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=111114.824/4031762.8638
=0.02755986

PT Metro Healthcare Indonesia Tbk's gearing of this year was 0.12883447. PT Metro Healthcare Indonesia Tbk's gearing of last year was 0.02755986. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=515844.799/615638.976
=0.83790146

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=505463.456/874075.011
=0.57828384

PT Metro Healthcare Indonesia Tbk's current ratio of this year was 0.83790146. PT Metro Healthcare Indonesia Tbk's current ratio of last year was 0.57828384. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PT Metro Healthcare Indonesia Tbk's number of shares in issue this year was 33250. PT Metro Healthcare Indonesia Tbk's number of shares in issue last year was 33250. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=254130.169/482927.907
=0.52622796

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=102082.226/315185.015
=0.32388033

PT Metro Healthcare Indonesia Tbk's gross margin of this year was 0.52622796. PT Metro Healthcare Indonesia Tbk's gross margin of last year was 0.32388033. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=482927.907/3981492.936
=0.12129317

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=315185.015/4086346.595
=0.07713125

PT Metro Healthcare Indonesia Tbk's asset turnover of this year was 0.12129317. PT Metro Healthcare Indonesia Tbk's asset turnover of last year was 0.07713125. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Metro Healthcare Indonesia Tbk has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Piotroski F-Score of 8 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. This is 100% above median its historical median of 4.00. Over the past decade, PT Metro Healthcare Indonesia Tbk's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #17 out of 650 companies in the Healthcare Providers & Services industry, placing it in the top 2.6%.
Is PT Metro Healthcare Indonesia Tbk's Piotroski F-Score too high?
PT Metro Healthcare Indonesia Tbk's current Piotroski F-Score of 8 is 100% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. PT Metro Healthcare Indonesia Tbk's value of 8 is 60% above this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #17 out of 650 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #17 out of 650 companies for Piotroski F-Score. This places PT Metro Healthcare Indonesia Tbk in the top 3% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. PT Metro Healthcare Indonesia Tbk's value of 8 is 60% above this benchmark. Historically, PT Metro Healthcare Indonesia Tbk's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, PT Metro Healthcare Indonesia Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 650 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current Piotroski F-Score is 8, which is 100% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp364.97, compared to a current price of Rp414.00 — trading 13.4% above its estimated fair value. The current Piotroski F-Score is 8, which is 100% above median its 10-year median of 4.00 and 60% above the Healthcare Providers & Services industry median of 5.00. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Piotroski F-Score is 8 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued. The current stock price of Rp414.00 is trading 13.4% above its estimated GF Value™ of Rp364.97. GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.

Key valuation signals for ISX:CARE:

  • Piotroski F-Score: 8 (100% above median its 10-year median of 4.00)
  • GF Value™: Rp364.97 vs. price of Rp414.00 (13.4% above fair value)
  • GF Score™: 77/100 with 2 warning signs
  • Industry Position: 60% above the Healthcare Providers & Services median (#17 of 650)

No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Metro Healthcare Indonesia Tbk Business Description

Address Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
77GF Score

Get the complete analysis for ISX:CARE

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp414.00
Price
Rp364.97
GF Value